A method to quantify at late imaging a release rate of 18F-FDG in tissues

Comptes Rendus - Biologies

Volumn 328, Issue 8, 2005, Pages 767-772

  Laffon, Éric ^a,b   Allard, Michèle ^a   Marthan, Roger ^b   Ducassou, Dominique ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b INSERM   (France)

Author keywords

18F FDG release; k4; Kinetic modelling; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; PHLORIZIN; TRACER;

METHODOLOGY;

ANALYTIC METHOD; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; COMPARTMENT MODEL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG RELEASE; HYDRATION; INJECTION; METHODOLOGY; QUANTITATIVE ANALYSIS; THEORETICAL STUDY;

FLUORODEOXYGLUCOSE F18; HUMANS; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 23944489567     PISSN: 16310691     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crvi.2005.06.004     Document Type: Article

References (13)

1. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat J. Neurochem. 28 1977 897-916
2. C.S. Patlak R.G. Blasberg Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: Generalizations J. Cereb. Blood Flow Metab. 5 1985 584-590
3. N. Sadato T. Tsuchida S. Nakamura A. Waki H. Uematsu N. Takahashi N. Hayashi Y. Yonekura Y. Ishii Non-invasive estimation of the net influx constant using the standardized uptake value for quantification of FDG uptake of tumours Eur. J. Nucl. Med. 25 1998 59-564
4. N.M. Freedman S.K. Sundaram K. Kurdziel J.A. Carrasquillo M. Whatley J.M. Carson D. Sellers S.K. Libutti J.C. Yang S.L. Bacharach Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scans Eur. J. Nucl. Med. 30 2003 46-53
5. 18F]fluoro-2-deoxy- d -glucose in tissues Nucl. Med. Commun. 25 2004 851-854
6. M. Ichise J.-H. Meyer Y. Yonekura An introduction to PET and SPECT neuroreceptor quantification models J. Nucl. Med. 42 2001 755-763
7. S. Okazumi K. Isono K. Enomoto T. Kituchi M. Osaki H. Yamamoto H. Hayashi T. Asano M. Ryu Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: Characterization of tumor and assessment of effect of treatment J. Nucl. Med. 33 1992 333-339
8. M.E. Phelps S.C. Huang E.J. Hoffman C. Selin L. Sokoloff D.E. Kuhl Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy- d -glucose: Validation of method Ann. Neurol. 6 1979 371-388
9. S. Eberl A.R. Anayat R.R. Fulton P.K. Hooper M.J. Fulham Evaluation of two population-based input functions for quantitative neurological FDG PET studies Eur. J. Nucl. Med. 24 1997 299-304
10. 18F-FDG kinetics and gene expression in giant cell tumors J. Nucl. Med. 45 2004 1528-1535
11. J.K. Moran H.B. Lee M.D. Blaufox Optimization of urinary FDG excretion during PET imaging J. Nucl. Med. 40 1999 1352-1357
12. J.R.L. Ehrenkranz N.G. Lewis C.R. Kahn J. Roth Phlorizin: A review Diabetes Metab. Res. Rev. 21 2005 31-38
13. 18F-FDG PET for the evaluation of pulmonary nodules J. Nucl. Med. 43 2002 871-875